Telix Pharmaceuticals Limited
TLPPF
$16.05
-$0.1419-0.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.75% | -11.79% | -34.88% | 85.73% | -0.47% |
| Total Depreciation and Amortization | -2.75% | -9.47% | 91.12% | -27.67% | -0.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.75% | 13.74% | 241.88% | -232.05% | -0.47% |
| Change in Net Operating Assets | 2.75% | -- | -- | -- | 0.47% |
| Cash from Operations | -2.75% | -94.03% | 515.45% | 3.94% | -0.47% |
| Capital Expenditure | 2.75% | -430.45% | 2.79% | 27.99% | 0.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.75% | 83.11% | -- | -- | 0.50% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.75% | -155.88% | -75.38% | 16.62% | 0.47% |
| Cash from Investing | 2.75% | -22.98% | -315.23% | 20.43% | 0.47% |
| Total Debt Issued | 0.00% | 21,631.14% | 25.56% | -26.83% | 0.00% |
| Total Debt Repaid | 0.00% | 17.49% | -- | -- | 0.00% |
| Issuance of Common Stock | 0.00% | -61.25% | 188.96% | -91.25% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -363.43% | 200.00% | -- | -- |
| Cash from Financing | -2.75% | 8,847.71% | 347.48% | -153.90% | -0.47% |
| Foreign Exchange rate Adjustments | -2.75% | 589.28% | -195.47% | 541.79% | 0.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 7,868.55% | -633.23% | 87.43% | 0.47% |
